RESPONSIVENESS OF ULTRASOUND SYNOVITIS AND CLINICAL OUTCOMES IN PSORIATIC ARTHRITIS TREATED WITH SECUKINUMAB: DATA FROM THE ULTIMATE TRIAL

Boers M, Conaghan PG, Schett G, Mandl P, Naredo E, Van Den Bosch F, Burgos-Vargas R, Duggan AM, Goyanka P, Gaillez C, D'Agostino MA (2021)

Publication Type: Conference contribution

Publication year: 2021

Journal

Annals of the Rheumatic Diseases BMJ Publishing Group

Publisher: BMJ PUBLISHING GROUP

City/Town: LONDON

Pages Range: 314-314

Conference Proceedings Title: ANNALS OF THE RHEUMATIC DISEASES

DOI: 10.1136/annrheumdis-2021-eular.1720

Authors with CRIS profile

Georg Schett Lehrstuhl für Innere Medizin III

Involved external institutions

Vrije Universiteit Amsterdam (VU) / University Amsterdam

Netherlands (NL) University of Leeds

United Kingdom (GB) Medizinische Universität Wien

Austria (AT) Hospital Universitario Fundación Jiménez Díaz

Spain (ES) Universiteit Gent (UGent) / Ghent University

Belgium (BE) Hospital General de México

Mexico (MX) Novartis Ireland Limited

Ireland (IE) Novartis India

India (IN) Novartis AG

Switzerland (CH) Catholic University of the Sacred Heart / Università Cattolica del Sacro Cuore

Italy (IT)

How to cite

APA:

Boers, M., Conaghan, P.G., Schett, G., Mandl, P., Naredo, E., Van Den Bosch, F.,... D'Agostino, M.A. (2021). RESPONSIVENESS OF ULTRASOUND SYNOVITIS AND CLINICAL OUTCOMES IN PSORIATIC ARTHRITIS TREATED WITH SECUKINUMAB: DATA FROM THE ULTIMATE TRIAL. In ANNALS OF THE RHEUMATIC DISEASES (pp. 314-314). LONDON: BMJ PUBLISHING GROUP.

MLA:

Boers, M., et al. "RESPONSIVENESS OF ULTRASOUND SYNOVITIS AND CLINICAL OUTCOMES IN PSORIATIC ARTHRITIS TREATED WITH SECUKINUMAB: DATA FROM THE ULTIMATE TRIAL." Proceedings of the ANNALS OF THE RHEUMATIC DISEASES LONDON: BMJ PUBLISHING GROUP, 2021. 314-314.

BibTeX: Download